SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nuvelo (Nasdaq: NUVO)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (49)7/25/1999 5:54:00 PM
From: Mike McFarland  Read Replies (1) of 286
 
They certainly seem to have enough going on
to support the 50M marketcap. But more
importantly, the cash position is great,
so long as the SBH thing with Affy doesn't
bite back. Any of the other true biofreaks'
opinion is worth so much more than my call
on any of this stuff, you sure you're asking me?

I'd surf around and find out what Kirin is all
about--and review what other deals Hyseq has
going. Sometimes smart pharma leads you to
good stuff--SmithKline was the first to do
a database deal with glgc...I thought that was
interesting...I'll have to hunt around and
see who did the first big deal for Hyseq's
database products.

You may recall that I found some stuff about
Chiron and Hyseq...let me grab that link again
for you:
Message 10411524
--just append to the end of that note...then I swapped
it out for glgc, then I regretted doing that...then I
spun around with my head cut off, etc etc ;-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News